Strategies toward single-donor islets of Langerhans transplantation

scientific article published on December 2011

Strategies toward single-donor islets of Langerhans transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/MOT.0B013E32834CFB84
P932PMC publication ID3268080
P698PubMed publication ID22068022

P2093author name stringA M James Shapiro
P2860cites workIslet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimenQ28141785
Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude miceQ33803861
A new method for incorporating functional heparin onto the surface of islets of LangerhansQ34238228
Islet transplantation for brittle type 1 diabetes: the UIC protocolQ34774804
Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockadeQ34976218
XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetesQ40381268
Insulin independence after living-donor distal pancreatectomy and islet allotransplantationQ40423359
Recovery from diabetes in mice by beta cell regenerationQ42408079
Automated method for isolation of human pancreatic isletsQ42516583
Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant successQ43153441
Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunctionQ43225003
Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in cultureQ43263229
Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice.Q43669824
Single-donor, marginal-dose islet transplantation in patients with type 1 diabetesQ45267369
Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide.Q46170683
Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic miceQ46345366
Low molecular weight dextran sulfate is well tolerated in humans and increases endogenous expression of islet protective hepatocyte growth factorQ47203503
High-density culture of human islets on top of silicone rubber membranesQ47688191
Effect of tumor necrosis factor alpha and of the soluble tumor necrosis factor receptor on insulin secretion of isolated islets of LangerhansQ67867806
Unraveling the secrets of single donor success in islet transplantationQ76316313
Effect of exenatide on beta cell function after islet transplantation in type 1 diabetesQ79552575
Repurification: rescue rather than routine remedyQ81239019
Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantationQ81790383
Changing pattern of organ donation at a single center: are potential brain dead donors being lost to donation after cardiac death?Q82272024
Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1β and TNF-αQ83591286
The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in miceQ84149425
Anti-inflammatory properties of exenatide in human pancreatic isletsQ84349939
P433issue6
P304page(s)627-631
P577publication date2011-12-01
P1433published inCurrent opinion in organ transplantationQ26842426
P1476titleStrategies toward single-donor islets of Langerhans transplantation
P478volume16

Reverse relations

cites work (P2860)
Q39346862A Multicenter Study: North American Islet Donor Score in Donor Pancreas Selection for Human Islet Isolation for Transplantation
Q38126385Anti-inflammatory strategies to enhance islet engraftment and survival
Q35151554Beneficial effect of insulin treatment on islet transplantation outcomes in Akita mice.
Q90646990Beneficial effects of the novel marine oxygen carrier M101 during cold preservation of rat and human pancreas
Q38126884Biologic agents in islet transplantation
Q87039180Current status of clinical islet transplantation
Q38103329Effects of donor-, pancreas-, and isolation-related variables on human islet isolation outcome: a systematic review.
Q34132207Ex vivo Expansion of Human Adult Pancreatic Cells with Properties of Distributed Stem Cells by Suppression of Asymmetric Cell Kinetics
Q41817143Filtration is a time-efficient option to Histopaque, providing good-quality islets in mouse islet isolation
Q27002000Human pancreatic islet transplantation: an update and description of the establishment of a pancreatic islet isolation laboratory
Q42152837Human α1-Antitrypsin Binds to Heat-Shock Protein gp96 and Protects from Endogenous gp96-Mediated Injury In vivo
Q50856415Human α1-antitrypsin modifies B-lymphocyte responses during allograft transplantation.
Q35882545Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist
Q35227182Inducible VEGF expression by human embryonic stem cell-derived mesenchymal stromal cells reduces the minimal islet mass required to reverse diabetes
Q27010290Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges
Q37098988Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation
Q36030491Lung-Derived Microscaffolds Facilitate Diabetes Reversal after Mouse and Human Intraperitoneal Islet Transplantation
Q34603880Maintenance of islet morphology is beneficial for transplantation outcome in diabetic mice.
Q38210810Minimizing immunosuppression in islet xenotransplantation.
Q47787665Modular tissue engineering for the vascularization of subcutaneously transplanted pancreatic islets.
Q40597576National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities
Q55411971New Automatized Method of 3D Multiculture Viability Analysis Based on Confocal Imagery: Application to Islets and Mesenchymal Stem Cells Co-Encapsulation.
Q47862186Novel Fusion Protein Targeting Mitochondrial DNA Improves Pancreatic Islet Functional Potency and Islet Transplantation Outcomes
Q52684486Oxygen-permeable microwell device maintains islet mass and integrity during shipping.
Q38218567Pancreatic islet transplantation: from dogs to humans and back again
Q36523515Preculturing Islets With Adipose-Derived Mesenchymal Stromal Cells Is an Effective Strategy for Improving Transplantation Efficiency at the Clinically Preferred Intraportal Site.
Q35322638Simultaneous silencing of multiple RB and p53 pathway members induces cell cycle reentry in intact human pancreatic islets
Q34079626Stimuli sensitive polymers and self regulated drug delivery systems: a very partial review
Q42565984Temperature profiles of different cooling methods in porcine pancreas procurement.
Q36263810The Spleen Is an Ideal Site for Inducing Transplanted Islet Graft Expansion in Mice
Q37340689Transplantation of human islets without immunosuppression
Q39899937Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes.